Certolizumab Pegol for the Treatment of Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Overview of 3 Randomized Controlled Trials

Main Article Content

Andrew Blauvelt
Kristian Reich
Mark Lebwohl
Daniel Burge
Catherine Arendt
Luke Peterson
Robert Rolleri
Alice Gottlieb

Keywords

certolizumab, psoriasis, clinical trial

Abstract

Abstract not available.

 

Disclosures: Study sponsored by UCB Pharma.

 

Copyright 2018 SKIN